Growth Metrics

Sonoma Pharmaceuticals (SNOA) Change in Account Payables (2016 - 2025)

Sonoma Pharmaceuticals has reported Change in Account Payables over the past 16 years, most recently at $229000.0 for Q4 2025.

  • For Q4 2025, Change in Account Payables fell 64.5% year-over-year to $229000.0; the TTM value through Dec 2025 reached $141000.0, down 76.42%, while the annual FY2025 figure was $416000.0, 249.64% up from the prior year.
  • Change in Account Payables for Q4 2025 was $229000.0 at Sonoma Pharmaceuticals, up from -$666000.0 in the prior quarter.
  • Over five years, Change in Account Payables peaked at $1.0 million in Q2 2025 and troughed at -$981000.0 in Q3 2022.
  • A 5-year average of -$46100.0 and a median of $30000.0 in 2021 define the central range for Change in Account Payables.
  • Biggest five-year swings in Change in Account Payables: skyrocketed 1410.71% in 2022 and later tumbled 1900.0% in 2025.
  • Year by year, Change in Account Payables stood at -$288000.0 in 2021, then soared by 171.18% to $205000.0 in 2022, then plummeted by 170.24% to -$144000.0 in 2023, then skyrocketed by 547.92% to $645000.0 in 2024, then crashed by 64.5% to $229000.0 in 2025.
  • Business Quant data shows Change in Account Payables for SNOA at $229000.0 in Q4 2025, -$666000.0 in Q3 2025, and $1.0 million in Q2 2025.